See All Slides - tctmd.com

Slides

Presentation ACC 2014

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS)

Presenter: M. Valgimigli

March 31, 2014

Presentation ACC 2014

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease

Presenter: Darren Mylotte

March 30, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

Presentation PCI Outcomes 2014

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Presenter: Dominick J. Angiolillo

March 28, 2014

Presentation PCI Outcomes 2014

Case Study 1: PCI vs. Optimal Medical Therapy in Stable CAD

Presenter: Sripal Bangalore

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Case Studies: Multi-Modality LM Evaluation

Presenter: Puja B. Parikh

March 28, 2014

Presentation PCI Outcomes 2014

BMS, DES, and BRS: A “Rational”Approach for Stent Selection

Presenter: Tullio Palmerini

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Fractional Flow Reserve for the Assessment Multi-Vessel Disease

Presenter: Peter F. Robinson

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Can IVUS (or OCT) be Used to Determine Lesion Significance? - Updates from VERDICT/FIRST

Presenter: Akiko Maehara

March 28, 2014

Presentation PCI Outcomes 2014

PCI vs. Optimal Medical Therapy in Stable Ischemic Heart Disease: Has the Last Year Brought More Clarity or Confusion?

Presenter: Ajay J. Kirtane

March 28, 2014

Advertisement

Slides

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS)

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Case Study 1: PCI vs. Optimal Medical Therapy in Stable CAD

Case Studies: Multi-Modality LM Evaluation

BMS, DES, and BRS: A “Rational”Approach for Stent Selection

Fractional Flow Reserve for the Assessment Multi-Vessel Disease

Can IVUS (or OCT) be Used to Determine Lesion Significance? - Updates from VERDICT/FIRST

PCI vs. Optimal Medical Therapy in Stable Ischemic Heart Disease: Has the Last Year Brought More Clarity or Confusion?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content